Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic investigation of antiinfective therapy in healthy subjects and severely burned ICU patients
2017-002216-14Phase 4Active
- Sponsor
- Clinical Pharmacology
- Start
- Jun 2017
- Modality
- Small Molecules, Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of ceftriaxone, clindamycin, meropenem, vancomycin, cefuroxime and 3 more in bacterial disease and mycoses (2 cohorts), sponsored by Clinical Pharmacology. Primary endpoints: Area under the concentration-time curve, Maximum concentration and 4 more. Started Jun 2017; status: active.
02
Drugs
ceftriaxoneclindamycinmeropenemvancomycincefuroxime
03
Conditions
bacterial diseasemycoses
Beyond the preview
Go deeper on 2017-002216-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002216-14.